GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nuformix PLC (LSE:NFX) » Definitions » Growth Rank

Nuformix (LSE:NFX) Growth Rank : 0 (As of May. 24, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Nuformix Growth Rank?

Nuformix has the Growth Rank of 0.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.


Nuformix Growth Rank Related Terms

Thank you for viewing the detailed overview of Nuformix's Growth Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


Nuformix (LSE:NFX) Business Description

Traded in Other Exchanges
Address
60 Gracechurch Street, 6th Floor, London, GBR, EC3V 0HR
Nuformix PLC is a pharmaceutical development company. It operates in the field of pharmaceutical development targeting unmet medical needs in fibrosis and oncology via drug repurposing. Its pipeline products include NXP001, NXP002, and NXP004. Geographically, the company operates only in the UK.

Nuformix (LSE:NFX) Headlines

From GuruFocus

Newfield Exploration Company (NFX) EVP and CFO Terry W Rathert sells 40,000 Shares

By GuruFocus Research GuruFocus Editor 03-12-2010

5 Oil & Gas Companies To Consider This Year

By InvestmentUnderground InvestmentUnderground 03-25-2012

Newfield Exploration Company (NFX) EVP and COO Gary D Packer sells 10,000 Shares

By GuruFocus Research GuruFocus Editor 12-29-2009

Newfield's Production Plans: Everything You Need to Know

By Sarfaraz A. Khan Sarfaraz A. Khan 12-27-2013